Mathias Goyen, Prof. Dr.med.

3/4 of physicians in a clinical study conducted at Klinikum Stuttgart reported enhanced communication with patients who’ve used Ada, contributing to more effective consultations. The Ada assessment report, downloaded by our users and used as a discussion guide with their doctors, includes key information such as: • Suggested conditions in order of likelihood • Associated level of care • Next steps on how and where to obtain a formal diagnosis • A summary of symptoms reported as present and absent Explainability lines between symptoms reported and conditions suggested ensure that our users have the information they need to hold meaningful and efficient conversations with their clinicians and pursue the right care. That’s because at Ada, we believe our clinical AI should not only be safe, accurate, and explainable but also actionable.

27

Learn more and discover complexities of sports cardiology and the impact of echocardiography: https://urls.fr/OSM6Gr #Vivid #Echofirst #Olympics2024 #Paris #GEHealthCare #Cardiology

3

Working in Endoscopy, GI or GI–oncology? We invite you watch this interview with Professor Helmut Messman, head of the Interventional Endoscopy Centre, at the University Hospital of Augsburg in Germany, as he discusses both the current and future significance of Artificial Intelligence in GI-endoscopy and the growing role of endoscopy in oncology. Professor Messman spoke after the recent Falk Symposium ‘Endoscopy in GI – Oncology: Standards and Innovations’ which took place in Copenhagen March 14th – 16th. ‘These two days showed us that the endoscopy really plays an enormous role in the early diagnosis and treatment of cancer, but also in advanced cancers, with a direct impact on patient quality of life,’ he explains. ‘Endoscopy is now a major player in GI oncology’. Prof Messman, who was one of the scientific organisers of the event, also comments on the ‘AI in Gastroenterology’ Workshop which took place during the symposium. ‘The AI workshop brought together international experts from all over the world and there was much lively debate and discussion. We learned how fast AI is developing. AI will revolutionise medicine, including gastroenterology and especially endoscopy and there is probably a need to have a yearly update on this topic.’ To view the interview in full visit: https://lnkd.in/egyRS_kY #Endoscopy #GIOncology #AIEndoscopy #Gastroenterology #Gastriccancer #UpperGI 

5

Worth watching this interview, the Professor discusses the current and future significance of Artificial Intelligence in GI-endoscopy, fascinating.

1

Valve-in-MAC with 29 mm Sapien 3 in a 76-year-old male successfully performed via transeptal access by Professor Sagar Doshi BSc MBChB FRCP MD FACC and Dr. Adnan Nadir MD FACC FESC at University Hospitals Birmingham NHS Foundation Trust A heavily comorbid 76-year-old male was admitted with pulmonary oedema. 30 months earlier he underwent TAVR with a 26 mm Sapien 3 Ultra. Echocardiography showed severe calcific mitral stenosis with a mean mitral valve gradient of 11 mm Hg. The aortic THV was well-functioning. He was deemed prohibitive risk for open heart surgery by the Heart Team. Gated CT showed significant mitral annular calcification (MAC score 5). On modelling with 3 Mensio the neo LVOT was measured at 377 mm²with a 29 mm Sapien 3. Mitral annular area on CT was 520 mm². Percutaneous valve in MAC with a 29 mm Sapien 3 was planned. Transseptal puncture was performed with the Boston Versacross system. A small curve Safari wire was positioned in the left ventricle together with the Versacross wire as a buddy. Septostomy was performed with a 12 mm Mustang balloon. The Sapien valve was deployed without pacing. A good position was obtained (80% ventricular). There was no transvalvular regurgitation and only a minor para valvular jet. Mean mitral valve gradient was reduced to 3 mm Hg. The patient was discharged at 14 days after a stormy inpatient stay complicated by GI bleeding. The Edwards Sapien M3 system will soon receive CE Mark and it is hoped that this will greatly improve the safety and predictability of valve in MAC procedures by mitigating the risk of LVOT obstruction and eliminating the risk of migration/embolization. Professor Sagar Doshi BSc MBChB FRCP MD FACC Dr. Adnan Nadir MD FACC FESC Edwards Lifesciences Boston Scientific Cardiology # Sapien M3 system

148

11 Kommentare

What if surgery could be effective, minimally invasive, and safe, helping patients recover faster and get back to their daily activities sooner? Could ultrasound-guided procedures be an answer? Two leading experts, Prof. PD Dr. Alexander Loizides and Univ.-Prof. Dr. Hannes GRUBER, will discuss the latest advancements in ultrasound-guided minimally invasive techniques. From procedures like carpal tunnel release to innovative methods beyond nerve compression, this webinar offers essential knowledge for enhancing clinical practice. Join us on December 17 at 7 pm (CET) for this interactive session to engage with experts and explore how to implement these innovations into your practice. Register now https://bit.ly/3CZzC5B #MSKWebinar #UltrasoundGuidedSurgery #CarpalTunnelRelease #CanonMedical #MadePossible

47

1 Kommentar

The most beneficial therapeutic role of the use of interventional pulmonology I feel, is in removing foreign bodies from the airways. It is one of the interventions which can lead to complete correction/ recovery. Sharing a good case https://lnkd.in/gezt3678

19

Full read JAMA ILD Review article. ILD= 33% idiopathic (IPF) + 15% hypersensitivity pneumonitis + 25% from CTD. 30% of ILD has cough Chest CT 91% sensitive, 71% specific 5% decr in FVC/12 mos assoc w/ 2-fold incr in mortality Rx options nintedanib or pirfenidone, TCZ, MMF, RTX https://buff.ly/424GQ2D

86

🚀 Exciting news from Dresden! The world's first whole-body MRI-guided #proton therapy ( #MRiPT) prototype was inaugurated at OncoRay – the National Center for Radiation Research in Oncology. This milestone signifies a leap forward in cancer treatment, with real-time MRI tracking promising to revolutionize precision therapy. Proton therapy provides a means to treat tumours with extreme precision. The finite range of a proton beam enables extremely conformal dose targeting with reduced dose to nearby healthy tissue. This high conformality, however, makes proton treatments particularly sensitive to anatomical changes in the beam path, which can impair the targeting precision when treating a moving target. Real-time imaging during treatment could help solve this drawback by synchronizing dose delivery with the tumour position. Aswin Hoffmann presented this prototype to Michael Kretschmer and Sebastian Gemkow ( PhysicsWorld reports ) https://lnkd.in/dPVsXypu #ProtonTherapy #MRI #CancerResearch #Innovation

118

1 Kommentar

💡 Insightful new study results on the impact of #ZeroGravity on significantly reducing occupational scatter radiation for Interventional cardiologists and sterile assistants in critical anatomical areas. The study highlights that:  ➡️ Implementing protection systems like Zero-Gravity can drastically reduce cathlab staff's exposure to scatter radiation during elective and emergency procedures.  ➡️ Given the well-documented long-term effects of occupational scatter radiation on Interventional cardiologists, advanced radiation protection devices like Zero-Gravity should be recommended in interventional cardiology practice guidelines. Thank you, Prof. Daniel Scherr, for presenting the research findings at the annual congress of the ÖKG. #RadiationSafety #OccupationalHealth

30

Outcomes of Balloon-Expandable Transcatheter Aortic Valve Replacement in Younger Patients: Key Insights from a Registry Analysis A recent analysis of 139,695 patients under 80 years old from the Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (TVT) Registry sheds light on outcomes of balloon-expandable TAVR using the SAPIEN valve family, spanning August 2019 to September 2023. The study explores a hypothesis: many younger patients with aortic stenosis may have significant comorbidities that limit life expectancy, reducing the need for repeat procedures. As a result, heart teams are thoughtfully balancing risks, benefits, and valve longevity when considering TAVR for younger patients with a shorter projected lifespan. Comparing patients younger than 65 to those aged 65–80 years, the study examined: Primary Outcomes: Mortality, stroke, and combined mortality or stroke were assessed in-hospital, at 30 days, and 1 year. Secondary Outcomes: Cardiac death, life-threatening bleeding, major vascular issues, new pacemaker need, dialysis, atrial fibrillation onset, valve reintervention, and readmissions. Health status was evaluated using the Kansas City Cardiomyopathy Questionnaire (KCCQ). Key Findings: 👉 Younger patients (<65 years) were more likely to have bicuspid aortic valves (25.2% vs. 7.6% in those 65–80; P < .001). 👉 Patients <65 years had higher 1-year readmission rates (28.2% vs. 26.1%; P < .001) and all-cause mortality (9.9% vs. 8.2%; P < .001). 👉 In propensity-matched comparisons, younger patients still had higher readmission rates at 1 year (28.2% vs. 26.8%; P < .03) and similar mortality to older patients (9.9% vs. 10.1%; P = .55). Conclusion: Younger patients with TAVR often face a high comorbidity burden, experiencing higher death and readmission rates at 1 year compared to older counterparts. These outcomes suggest that current heart team decision-making for TAVR in younger patients is sound, emphasizing careful risk assessment and tailored patient counseling. 📖 Read the full study here: https://lnkd.in/dcTmhpeW Mansoura University EACTS - European Association for Cardio-Thoracic Surgery European Society of Thoracic Surgeons European Trauma Course Organisation European Society of Cardiology Journal Cardiothoracic Vascular Anesthesia European Association of Cardiothoracic Surgery European Society of Thoracic Surgeons American Society of Anesthesiologists® Society of Cardiovascular Anesthesiologists EACTAIC - European Association of Cardiothoracic Anaesthesiology and Intensive Care SATA Transplant Anesthesia Seminars in Cardiothoracic and Vascular Anesthesia @NEJM JAMA Outcomes of Balloon-Expandable TAVR in Younger Patients: Key Insights from a Registry Analysis https://lnkd.in/dmwyBAui

7

🎯Super Short Review Series: Article #2 Managing Acute Decompensated Valvular Disease💔in the ICU 🏥 ➡️➡️➡️ Managing acute decompensated valvular disease in the ICU is complex. This article offers key insights, practical strategies, and highlights critical research gaps to improve care for critically ill patients. 💡 Key Insights from the Article: • Team-Based Care 🤝: Multidisciplinary Heart Teams are essential to optimize outcomes in these critically ill patients. • Bridging Therapies 🚑: like Balloon Aortic Valvuloplasty (BAV) and ECMO (with the LAVA technique) provide life-saving stabilization for unstable patients. • Advanced Hemodynamic Tools 🔍: Pulmonary artery catheters (PACs) are regaining importance in guiding treatment decisions. • Simple but Effective Interventions ✅: Positive Pressure Ventilation (PPV) not only supports breathing but also improves valve function. • Urgent Need for Inclusive Research 📚: ICU patients are underrepresented in clinical trials for tools like TAVR and TEER, leaving significant gaps in evidence. 📊 Key Figures and Takeaways: 1️⃣ Central Illustration – Overview of Valvular Disease Management Summarizes challenges and strategies for critically ill patients with valvular dysfunction, emphasizing tailored interventions and teamwork. 2️⃣ Figure 1 – Factors Influencing Surgical Decisions Outlines key considerations like frailty, comorbidities, and ventricular function that guide surgery, TAVR, or bridging therapies. 3️⃣ Figure 2 – Aortic Stenosis and Regurgitation Highlights diagnostic complexities and the role of Balloon Aortic Valvuloplasty (BAV) for high-risk patients. 🫀 🔑 Advanced imaging (TEE, CT) aids emergency decisions. 4️⃣ Figure 3 – Mechanical Circulatory Support (MCS) Focuses on ECMO and Impella for severe valvular failure. 🔑 LAVA technique with ECMO improves outcomes. 5️⃣ Figure 4 – Mitral Stenosis and Regurgitation Explains mitral valve dysfunction changes with TEER and PPV interventions. ⏱ 🔑 Timing of intervention is key. 6️⃣ Figure 6 – Impact of Positive Pressure Ventilation (PPV) Shows how PPV improves hemodynamics and mitral valve function in ICU. 7️⃣ Table 1 – Research Gaps Highlights the need for more clinical trial data for ICU patients on TAVR and TEER. 📥 Key figures and explanations will be shared in the comments—don’t miss them! 🙌 Special thanks to the authors for this incredible contribution to cardiology. 📖 Read the full article here: https://lnkd.in/enYPGpN5 🌎#FeelAliveNotJustSurvive 💡#Cardiology #ValvularDisease #ICU #CriticalCare #MedicalInnovation #TAVR #TEER #ECMO #HeartTeam #MedicalResearch #BAV

48

15 Kommentare

Stereotactic arrhythmia radiotherapy (STAR) has been recently proposed in patients with refractory ventricular tachycardia (VT). The purpose of this study was to describe the efficacy and safety of STAR in the Czech Republic. This cohort study investigated the efficacy and safety of stereotactic arrhythmia radiotherapy in patients with refractory ventricular tachycardia (VT). There was a significant reduction in the need for direct current shocks from ICDs; however, 47% of the patients required repeat catheter ablation owing to clinically relevant VT recurrences over a mean follow-up period of 13.7 months. These findings highlight patients with refractory VT as a high-risk clinical population as well as the potential risks associated with stereotactic arrhythmia radiotherapy. Further research is needed to inform careful patient selection and close monitoring after treatment. I hope you enjoy your reading! I wish us all a blessed week! Silvia🇧🇷

2

Invited Lecture by Dr. Yong Du; Associate Professor of Radiology, Johns Hopkins Medicine: "SPECT Imaging for Alpha Radiopharmaceutical Therapy" https://lnkd.in/efqEf42Z Chapter Breakdown: 0:00 Introduction 1:15 #Radiopharmaceutical Therapy (#RPT) 3:40 Beta and alpha RPTs 7:28 Rationale for #dosimetry in RPT 9:30 RPT treatment planning flowchart 14:15 Quantitative SPECT activity estimation 15:03 SPECT vs. PET 20:00 Challenges with #SPECT imaging of alpha-emitters 26:42 Solutions for imaging alpha emitters 34:30 Animal studies of Ac-225 35:23 Patient SPECT/CT imaging (Fr-221 and Bi-213) 36:02 New alpha SPECT systems 46:47 Conclusions

100

3 Kommentare

Enhancing Efficiency and Precision in Radiology with SmartReports 🚀 Prof. Dr. Dominik Nörenberg, Vice Chair of Clinical Operations at University Medical Center Mannheim shares how SmartReports has significantly boosted his radiology reporting efficiency. In a fast-paced academic center, time is of the essence. Since adopting SmartReports, Prof. Nörenberg has experienced a 20-30% improvement in reporting speed, thanks to seamless integration and smart features. Key highlights include: ✅ Customizable shortcuts for personalized speech commands ✅ Intelligent automation for repetitive tasks ✅ Sketch elements to depict complex anatomy ✅ Upcoming feature: Automatic measurement transfer from PACS, streamlining the reporting process even further. SmartReports is adaptable to various clinical workflows, whether dealing with routine exams or complex oncological studies. At the clinic, over 700 prostate MRIs and 700 cardiac CTs are reported annually using SmartReports, significantly enhancing accuracy and precision in every report. 👉 Read more about how SmartReports is helping to transform radiology reporting: https://lnkd.in/gmfwxmge #Radiology #MedicalTech #SmartReports #HealthcareInnovation #DigitalTransformation Universitätsmedizin Mannheim

57

HICs, IAEA, WHO and manufacturers can do so much to fill this gap. A global sustainable (e.g., equipment life cycle policy) plan could be an immediate solution but developing competent manpower is probably something we need to focus on as a starting point...

2

#quarterlyupdate on #sustainability in IR Sustainability within interventional radiology: opportunities and hurdles https://lnkd.in/dGbMNtgc #interventionalradiology #irad

2

This makes so much sense. Read for free in Heart Rhythm: https://lnkd.in/eefbeud4

16